Fundz
An acquisition means integration work is about to be scoped. Fundz scores the company against what you sell, and says why it matched.See it live →

Everest acquires Firma Clinical Research's data unit

PRIVATESep 17, 2026•about 3 hours ago

Acquiring Company

Everest Clinical Research Corporation

Acquired Company

Firma Clinical Research

BiotechnologyHealth CareBiotechnologyHealth Care

Description

Everest Clinical Research has acquired the Biometrics and Data Services business unit from Firma Clinical Research. This acquisition will enhance Everest's capabilities in global biometrics and clinical data science. With this move, Everest aims to improve the efficiency and quality of clinical research. This acquisition demonstrates Everest's commitment to expanding its expertise in the field.

Company Information

Company

Everest Clinical Research Corporation

About

Everest is a full-service contract research organization (“CRO”) providing a broad range of expertise-based clinical research services to worldwide pharmaceutical, biotechnology, and medical device industries. Everest serves some of the best-known companies and works with many of the most advanced drugs, biologics, and medical devices in development today. Founded in 2004, Everest has a strong foundation as a statistical and data management center of excellence. Building on this foundation, Everest has successfully developed and established itself as a full-service CRO. Operating primarily in North America, with headquarters located in Toronto, Ontario, Canada, a second office in Little Falls, New Jersey, USA and a third office in Shanghai, China, Everest is known in the industry for its high quality deliverables, superior customer service, and flexibility in meeting clients’ needs.

Don't miss Everest Clinical Research Corporation's next move

Get an email the moment Everest Clinical Research Corporation makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Everest Clinical Research Corporation's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Firma Clinical Research?

Firma Clinical Research was acquired by Everest Clinical Research Corporation. The deal was reported on September 17, 2026. Everest is a full-service contract research organization (“CRO”) providing a broad range of expertise-based clinical research services to worldwide pharmaceutical, biotechnology, and medical device industries. Everest Clinical Research Corporation is privately held and operates in Biotechnology.

When did Everest Clinical Research Corporation acquire Firma Clinical Research?

Everest Clinical Research Corporation's acquisition of Firma Clinical Research was reported on September 17, 2026. Everest Clinical Research has acquired the Biometrics and Data Services business unit from Firma Clinical Research. This acquisition will enhance Everest's capabilities in global biometrics and clinical data science. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Firma Clinical Research do?

Firma Clinical Research offers data services for clinical trials, supporting various aspects of clinical research. Its capabilities include biometrics and data management services. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.